Additionally, research should investigate how Sema and MI modulate microglial activity, particularly through GLP-1 receptor pathways, and evaluate their therapeutic effects on obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.